This is because a number of studies have demonstrated that multiple autoantibodies can be accumulated in the preclinical phase of RA,20, 21 possibly via the mechanism of epitope spreading, and ACPA usually appears before RF.22 It, therefore, seemed reasonable to consider baseline ACPA status a potential confounder. This evidence concerns the gene PRTN3 and rheumatoid arthritis.